|

Monalizumab (anti-NKG2A monoclonal antibody) Clinical Trials

1 actively recruiting trial

Also known as: humZ270, mAb IPH2201

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.